ConductScience.org, home

Paper36915713

Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways.

Zhang F and 12 others. Regen Biomater, 2023. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways. Papers, record 36915713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36915713

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways.
PubMed
Journal
Regen Biomater
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.73
iCite
Revised in PubMed
2024-11-25
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang FFengzhu
2Zhang AAiwen
3Xie YYouning
4Wen HHaiying
5Kankala RKRanjith Kumarhttps://orcid.org/0000-0003-4081-9179
6Huang JJing
7Zhang AAnjun
8Wang QQi
9Chen BBiaoqi
10Dong HHaiyan
11Guo ZZhao
12Chen AAizhenghttps://orcid.org/0000-0002-5840-3406
13Yang DDayun

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in39569075Correction to: Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways.https://conductscience.org/library/papers/39569075

Source PubMed

Download CSV of comments and corrections

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127899961The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC.Oncol Lett2016https://conductscience.org/library/papers/27899961PubMed
223201163Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.Cancer Cell2012https://conductscience.org/library/papers/23201163PubMed
328070573Nanoparticle delivery of Wnt-1 siRNA enhances photodynamic therapy by inhibiting epithelial-mesenchymal transition for oral cancer.Biomater Sci2017https://conductscience.org/library/papers/28070573PubMed
430844107Hypoxia/pseudohypoxia-mediated activation of hypoxia-inducible factor-1α in cancer.Cancer Sci2019https://conductscience.org/library/papers/30844107PubMed
528752598Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications.Adv Healthc Mater2017https://conductscience.org/library/papers/28752598PubMed
632296047Molecular principles of metastasis: a hallmark of cancer revisited.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32296047PubMed
721741598A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.Cancer Cell2011https://conductscience.org/library/papers/21741598PubMed
830451972Wnt-β-catenin signalling in liver development, health and disease.Nat Rev Gastroenterol Hepatol2019https://conductscience.org/library/papers/30451972PubMed
934952829Epigenetic basis and targeting of cancer metastasis.Trends Cancer2022https://conductscience.org/library/papers/34952829PubMed
1023390366All-trans retinoic acid-incorporated nanoparticles of deoxycholic acid-conjugated dextran for treatment of CT26 colorectal carcinoma cells.Int J Nanomedicine2013https://conductscience.org/library/papers/23390366PubMed
1132334405Epithelial-Mesenchymal Transition in Cancer: A Historical Overview.Transl Oncol2020https://conductscience.org/library/papers/32334405PubMed
1234197896Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).Adv Drug Deliv Rev2021https://conductscience.org/library/papers/34197896PubMed
1328741564Surviving at a Distance: Organ-Specific Metastasis.Trends Cancer2015https://conductscience.org/library/papers/28741564PubMed
1430975895Context-dependent EMT programs in cancer metastasis.J Exp Med2019https://conductscience.org/library/papers/30975895PubMed
1535332121Notch signaling pathway: architecture, disease, and therapeutics.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35332121PubMed
1621376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1729035746The exploration of endocytic mechanisms of PLA-PEG nanoparticles prepared by coaxialtri-capillary electrospray-template removal method.Colloids Surf B Biointerfaces2018https://conductscience.org/library/papers/29035746PubMed
1829665439Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer.Nanomedicine2018https://conductscience.org/library/papers/29665439PubMed
1930594349EMT Transition States during Tumor Progression and Metastasis.Trends Cell Biol2019https://conductscience.org/library/papers/30594349PubMed
2024816129A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer.Eur J Pharm Biopharm2014https://conductscience.org/library/papers/24816129PubMed

See all 53 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42823964A biomaterials roadmap from retinoic acid biology to kidney regenerative therapy.iScience2026https://conductscience.org/library/papers/42823964PubMed
41437379Dual-site spatiotemporal and simultaneous inhibition on PIN1 via arsenic-retinoic albumin nanoparticles enables synergistic oncotherapy.J Nanobiotechnology2025https://conductscience.org/library/papers/41437379PubMed
40385538Temperature-sensitive sodium beta-glycerophosphate/chitosan hydrogel loaded with all-trans retinoic acid regulates Pin1 to inhibit the formation of spinal cord injury-induced rat glial scar.Bioeng Transl Med2025https://conductscience.org/library/papers/40385538PubMed
39886975Pin1 as a central node in oncogenic signaling: Mechanistic insights and clinical prospects (Review).Mol Med Rep2025https://conductscience.org/library/papers/39886975PubMed
39199746Supercritical Fluids: An Innovative Strategy for Drug Development.Bioengineering (Basel)2024https://conductscience.org/library/papers/39199746PubMed
38476678Cancer cell response to extrinsic and intrinsic mechanical cue: opportunities for tumor apoptosis strategies.Regen Biomater2024https://conductscience.org/library/papers/38476678PubMed

Download CSV of cited by

Genes24

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDH21000PubTator's text mininghttps://conductscience.org/library/genes/1000NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MAPK35595PubTator's text mininghttps://conductscience.org/library/genes/5595NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
NOTCH14851PubTator's text mininghttps://conductscience.org/library/genes/4851NCBI Gene
NUS1116150PubTator's text mininghttps://conductscience.org/library/genes/116150NCBI Gene
PIK3R15295PubTator's text mininghttps://conductscience.org/library/genes/5295NCBI Gene
PIN15300PubTator's text mininghttps://conductscience.org/library/genes/5300NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
PTK2B2185PubTator's text mininghttps://conductscience.org/library/genes/2185NCBI Gene
RAF15894PubTator's text mininghttps://conductscience.org/library/genes/5894NCBI Gene
SNAI16615PubTator's text mininghttps://conductscience.org/library/genes/6615NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene
TWIST17291PubTator's text mininghttps://conductscience.org/library/genes/7291NCBI Gene

See all 24 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36915713

GET https://conductscience.org/api/papers/v1/36915713/references?page=2